# Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis

> **NCT05007795** · NA · NOT_YET_RECRUITING · sponsor: **University of Cape Town** · enrollment: 280 (estimated)

## Conditions studied

- Tuberculosis, Multidrug-Resistant

## Interventions

- **DIAGNOSTIC_TEST:** Targeted sequencing using the GenoScreen Deeplex assay

## Key facts

- **NCT ID:** NCT05007795
- **Lead sponsor:** University of Cape Town
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-05-31
- **Final completion:** 2028-10-30
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05007795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05007795, "Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05007795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*